Also, FOXD3-dependent upregulation of the EGFR family member ERBB3 was described after BRAF- or MEK inhibition in melanoma cells, resulting in enhanced responsiveness to ERBB3 ligands and the sensitization towards the BRAF inhibitor PLX4720 by lapatinib [41]. The gene discussed is FOXD3; the disease is melanoma.